middle.news

How Bioxyne’s GMP Certification Could Transform Its Global Reach

8:48am on Wednesday 18th of June, 2025 AEST Pharmaceuticals
Read Story

How Bioxyne’s GMP Certification Could Transform Its Global Reach

8:48am on Wednesday 18th of June, 2025 AEST
Key Points
  • Breathe Life Sciences obtains GMP compliance certificates recognized in Australia, Europe, UK, Canada, and Singapore
  • Certification under Mutual Recognition Agreements facilitates international market access
  • Focus on expanding presence in European Union, UK, and other high-growth markets
  • FY2026 growth outlook positive, with detailed guidance due in August
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Bioxyne (ASX:BXN)
OPEN ARTICLE